DNA ligase is the enzyme that seals breaks in the sugar-phosphate backbone of DNA, joining two adjacent nucleotides by forming a new chemical bond between them. Every time your cells copy their genome or patch up damage from sunlight, chemicals, or simple metabolic wear, a DNA ligase finishes the job by stitching the strand back together. Without it, your chromosomes would accumulate nicks that stall replication, trigger mutations, and ultimately threaten cell survival. The enzyme works across all domains of life, and its usefulness extends well beyond the cell: molecular biologists have turned it into one of their most essential laboratory tools.
How DNA Ligase Seals a Nick
DNA ligase works on a specific kind of damage: a nick where one strand of the double helix has a free end bearing a phosphate group on one side and a hydroxyl group on the other. The enzyme joins these two ends by creating a phosphodiester bond, the same type of linkage that holds every other pair of nucleotides together in the backbone. The reaction proceeds through three chemical steps that all depend on a small energy-carrier molecule as a cofactor. In human cells, that cofactor is ATP; in most bacteria, it is a different molecule called NAD+.
In the first step, the ligase grabs the cofactor and attaches part of it (an AMP group) to itself, charging up the enzyme. In the second step, that AMP group gets transferred onto the exposed phosphate at the nick, creating a short-lived intermediate on the DNA. In the third step, the hydroxyl group on the other side of the nick attacks that activated phosphate, the AMP departs, and the backbone is sealed. Structural studies have captured snapshots of these intermediates, confirming that a metal ion in the active site helps position the reacting groups and stabilize the transition state during that final bond-forming step.1PubMed Central. Structural intermediates of a DNA-ligase complex illuminate the role of the catalytic metal ion and mechanism of phosphodiester bond formation The final step happens fast: one estimate puts the rate of phosphodiester synthesis by DNA ligase at roughly 400 reactions per second, comparable to the speed of the polymerases that copy DNA during replication.2PubMed Central. Dynamics of phosphodiester synthesis by DNA ligase
Speed matters because the intermediate created in step two, where AMP sits on the broken DNA, is itself a potentially harmful lesion if left unresolved. A stalled ligase that walks away after step two but before step three would leave a modified nick that other repair enzymes would need to clean up. So the enzyme is built to complete the job quickly once it starts.
The Shape-Shifting Structure
Human DNA ligases are not rigid molecules. They are built from several connected domains that swing relative to one another depending on whether the enzyme is searching for a nick or actively sealing one. In the absence of DNA, the domains adopt an extended, open shape. When the enzyme encounters a nick, those domains wrap around the double helix, forming a ring-like clamp that encircles the DNA.3PubMed Central. DNA ligase I, the replicative DNA ligase This open-to-closed transition has been observed in crystallographic structures of multiple human DNA ligases, including DNA Ligase IV, where a subdomain undergoes a dramatic swivel to reposition itself and form extensive new contacts with the DNA substrate.4Nature Communications. Structures of DNA-bound human ligase IV catalytic core reveal insights into substrate binding and catalysis
This shape change is not just structural gymnastics. By completely encircling the DNA, the ligase ensures the reactive ends are held in precise alignment. A misaligned nick would lead to a failed reaction or, worse, ligation of the wrong ends. The clamp-like closure also helps the enzyme distinguish authentic nicks from other DNA features it should leave alone.
Sealing Okazaki Fragments During Replication
One of the most frequent jobs for DNA ligase happens every time a cell divides. Because of the way the replication machinery works, one of the two new DNA strands (the lagging strand) is synthesized in short segments. These segments need to be stitched together into a continuous strand. In human cells, that stitching is handled by DNA Ligase 1.
Ligase 1 does not work alone in this process. It is recruited to nicks with the help of a ring-shaped protein called PCNA that slides along the DNA like a clamp. Another enzyme, FEN1, first trims excess flap material left over from the previous segment. Structural studies using cryo-electron microscopy have shown that PCNA functions as a kind of toolbelt: both FEN1 and Ligase 1 can attach to it simultaneously, enabling an efficient handoff of the nicked DNA from the trimming enzyme to the sealing enzyme.5Nature Communications. Study reveals dynamics of DNA ligation during genome replication Once FEN1 departs, Ligase 1 wraps around the nick and completes the seal.6Molecules and Cells. Replication of the Lagging Strand: A Concert of at Least 23 Polypeptides
This ligation step is not merely a formality. Research in yeast has shown that when Ligase 1 (called Cdc9 in yeast) carries mutations that reduce its fidelity, the enzyme can seal nicks even when an extra base has been incorrectly inserted by the polymerase, leading to characteristic insertion mutations in the genome.7Nature Communications. High-fidelity DNA ligation enforces accurate Okazaki fragment maturation during DNA replication In other words, ligase is not just the glue; it also serves as a final quality-control checkpoint during replication.
Patching Single-Strand Breaks
DNA picks up single-strand breaks constantly from oxidative damage, radiation, and the normal activity of enzymes that need to temporarily cut the backbone. One of the main repair systems for these breaks is base excision repair, or BER. After a damaged base is removed and the correct nucleotide is filled in by a polymerase, a DNA ligase seals the remaining nick.
In human cells, this nick-sealing role was long attributed to DNA Ligase 3, which works in a complex with a scaffolding protein called XRCC1. XRCC1 coordinates the repair process, and the complex of XRCC1 and Ligase 3 has been shown to regulate whether repair proceeds by replacing just one nucleotide (short-patch repair) or several (long-patch repair), depending on whether enough ATP is available for ligation.8PubMed. Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER However, genetic experiments delivered a surprise: when researchers knocked out Ligase 3 in mouse cells, the cells survived and repaired DNA damage nearly normally, because Ligase 1 stepped in to handle the XRCC1-dependent repair work.9PubMed Central. Disconnecting XRCC1 and DNA ligase III This redundancy between ligases turns out to be a recurring theme.
Repairing Double-Strand Breaks
Double-strand breaks, where both strands of the helix are severed, are among the most dangerous forms of DNA damage. One of the primary pathways for fixing them is called non-homologous end joining (NHEJ), and it depends on a dedicated ligase: DNA Ligase 4. Ligase 4 works in a complex with a partner protein called XRCC4, and an additional factor called XLF helps stimulate the complex’s activity.10Cell. Human XLF Interacts with the XRCC4-DNA Ligase IV Complex, Promoting DNA Nonhomologous End-Joining
Single-molecule imaging experiments have revealed something interesting about how this complex assembles. Before the broken ends are brought together for ligation, two copies of the Ligase 4–XRCC4 complex are often present, but one dissociates just before the broken ends are synapsed, leaving a single Ligase 4 to carry out the actual seal.11Nature Communications. Structural role for DNA Ligase IV in promoting the fidelity of non-homologous end joining The NHEJ pathway also involves other factors like DNA-PKcs and the Ku proteins that recognize and protect the broken ends before ligation occurs.
Even when the main NHEJ pathway is knocked out, cells retain a backup route for joining double-strand breaks called alternative end-joining. Remarkably, either Ligase 1 or Ligase 3 can step in to catalyze this backup pathway. Experiments in mouse B cells showed that deleting Ligase 4 reduced but did not abolish the ability of cells to perform antibody class-switch recombination, a process that requires resolving programmed double-strand breaks. Deleting either Ligase 1 or Ligase 3 on top of the Ligase 4 deletion did not further reduce this activity, indicating that the two remaining ligases function redundantly in the alternative pathway.12PubMed Central. Redundant function of DNA ligase 1 and 3 in alternative end-joining during immunoglobulin class switch recombination
Keeping Mitochondrial DNA Intact
Mitochondria have their own small circular genome, and it turns out they depend on their own dedicated ligase activity. DNA Ligase 3 exists in two forms produced from the same gene: one goes to the nucleus, and one is directed to mitochondria. Early work in mouse cells showed that the mitochondrial copy of Ligase 3 is essential for cell survival, even though the nuclear copy is dispensable thanks to Ligase 1’s backup role. Remarkably, researchers could rescue Ligase 3-deficient cells by redirecting Ligase 1 or even a simple viral ligase into the mitochondria, demonstrating that what the organelle needs is any nick-sealing enzyme, not specifically Ligase 3 itself.13PubMed Central. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair
More recent work in human cells has refined this picture. When Ligase 3 was knocked out in human kidney cells, the cells survived with only a moderate drop in mitochondrial DNA copy number, and they continued to synthesize intact circular mitochondrial DNA. However, the cells showed increased accumulation of strand breaks in their mitochondrial genomes, especially at sites with high GC content, and they became dramatically vulnerable to oxidative stress. Exposing these cells to an oxidative challenge caused severe mitochondrial DNA loss, while wild-type cells recovered.14Nucleic Acids Research. Ligase 3 prevents oxidative strand break-induced mitochondrial DNA loss but is not essential for replicative circularization The picture that emerges is that Ligase 3’s critical mitochondrial role is less about routine replication and more about repairing the constant oxidative damage that mitochondrial DNA endures from its proximity to the cell’s energy-producing machinery.
Why Bacteria Use a Different Energy Source
Human DNA ligases and those of other eukaryotes use ATP to power the ligation reaction. Bacteria, by contrast, almost universally use NAD+ as their cofactor. This split in cofactor preference runs deep in the tree of life: ATP-dependent ligases predominate in eukaryotes and archaea, while NAD+-dependent ligases are found almost exclusively in bacteria.15PubMed. ATP- and NAD+-dependent DNA ligases share an essential function in the halophilic archaeon Haloferax volcanii Some bacteria do carry genes for ATP-dependent ligases as well, but phylogenetic analysis suggests these were picked up on separate occasions from archaeal or viral sources rather than being ancestral.16PubMed. Bacterial DNA ligases
This difference matters practically because it makes bacterial NAD+-dependent ligase an attractive drug target. Since human cells do not have this enzyme, a drug that specifically blocks it should in principle leave human ligases untouched. Researchers have pursued this idea with some success, identifying compounds that inhibit bacterial ligase across multiple species and reduce bacterial counts by as much as a thousandfold in animal infection models.17PubMed Central. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo Other groups have used structural analysis of bacterial ligase binding pockets to find inhibitors that avoid known resistance mutations, a crucial step toward keeping any future antibiotic effective.18PubMed. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations
T4 DNA Ligase in the Laboratory
If you have ever heard of DNA ligase outside a biology class, it was probably T4 DNA ligase, the workhorse enzyme of molecular cloning. Derived from a virus that infects bacteria, T4 DNA ligase is smaller and simpler than its human counterparts, and structural work suggests it may resemble an evolutionary ancestor of the larger cellular ATP-dependent ligases.19PubMed Central. T4 DNA ligase structure reveals a prototypical ATP-dependent ligase with a unique mode of sliding clamp interaction What makes it so useful in the lab is its versatility.
T4 DNA ligase efficiently joins DNA fragments with complementary sticky ends (the short single-stranded overhangs left by many restriction enzymes), and it also joins blunt-ended fragments, though less efficiently. Comparative analysis has shown that its blunt-end and two-base-overhang activity is stronger than its activity on single-base overhangs.20PLoS ONE. Comparative analysis of the end-joining activity of several DNA ligases It can even ligate ends that do not match at all: experiments demonstrated that T4 DNA ligase joins blunt ends to ends with short overhangs, with the overhang being trimmed away during the process, at efficiencies comparable to standard blunt-end ligation.21PubMed. Ligation of nonmatching DNA molecule ends This flexibility is what makes it indispensable for inserting a gene fragment into a plasmid vector, constructing recombinant DNA molecules, and countless other cloning workflows.
Beyond traditional cloning, T4 DNA ligase is a critical component of next-generation sequencing library preparation. Several methods use it to attach adapter sequences onto DNA fragments so they can be read by sequencing instruments. One approach uses T4 DNA ligase to join single-stranded adapters onto highly degraded DNA via a splinter oligonucleotide, enabling sequencing of ancient or forensic samples that would otherwise yield too little material.22Nucleic Acids Research. Single-stranded DNA library preparation from highly degraded DNA using T4 DNA ligase Another method, called SRSLY, combines phosphorylation and ligation into a single reaction step, simplifying the workflow for preparing libraries from cell-free DNA and other short fragments.23PubMed Central. A ligation-based single-stranded library preparation method to analyze cell-free DNA and synthetic oligos
DNA Ligase as a Diagnostic Sensor
The stringent substrate requirements of DNA ligases have been turned into a diagnostic advantage. Because a ligase efficiently seals a nick only when the bases on either side are correctly paired with the template strand, researchers have devised assays where ligation acts as a readout for whether a specific DNA sequence is present in a sample. In the oligonucleotide ligation assay, two short probes are designed to sit side by side on a target sequence. If the target is present and the bases match perfectly, the ligase joins them; if even a single nucleotide differs at the junction, ligation is inhibited. This allows detection of single-nucleotide variants, which is useful for genotyping, pathogen identification, and screening for disease-associated mutations.24Nucleic Acids Research. A ligase-based toolbox for research and diagnostics in molecular medicine
A related technique uses padlock probes: linear oligonucleotides whose two ends hybridize to adjacent sites on a target, and upon ligation, the probe circularizes. The resulting DNA circle can then be amplified by rolling-circle amplification, producing a large detectable signal from a single ligation event. These approaches exploit the enzyme’s natural insistence on a perfect substrate, repurposing what evolved as a fidelity mechanism into a diagnostic tool.
When Ligase Goes Wrong in Human Disease
Given how central DNA ligases are to genome maintenance, it is not surprising that mutations in ligase genes cause disease. Mutations in the gene encoding DNA Ligase 4 lead to a condition known as LIG4 syndrome, characterized by immune abnormalities including altered T and B cell counts, increased radiosensitivity, and low antibody levels. Even individuals who carry the mutations without obvious symptoms can show measurable immune irregularities.25PubMed Central. Ligase-4 deficiency causes distinctive immune abnormalities in asymptomatic individuals Because Ligase 4 is essential for NHEJ, which in turn is required for assembling the gene segments that encode antibodies and T cell receptors, a defective Ligase 4 directly impairs the adaptive immune system.
Mutations in DNA Ligase 1 cause a separate condition called LIG1 syndrome, also a primary immunodeficiency. Several specific mutations have been identified, including changes at positions R641L and R771W, that reduce the enzyme’s nick-sealing ability through different mechanisms.26PubMed Central. Rare variants of DNA ligase 1 show distinct mechanisms of deficiency These are rare pediatric conditions, but studying them has provided valuable insights into which cellular functions each ligase handles and how much overlap exists between them.
Targeting DNA Ligases in Cancer
Cancer cells often have defects in one DNA repair pathway, forcing them to lean heavily on an alternative pathway to survive. This creates a vulnerability: if you block the backup pathway, the cancer cell dies while normal cells, which still have both pathways intact, are spared. This concept, called synthetic lethality, has been successfully exploited with PARP inhibitors in cancers carrying BRCA mutations. Researchers are now finding that DNA Ligase 1 fits into a similar strategy.
A CRISPR-based screen identified Ligase 1 as a synthetic lethal target in BRCA1-mutant breast and ovarian cancers. Inactivating Ligase 1 caused cell death across multiple BRCA1-mutant cell lines while leaving BRCA-normal cells unharmed, and in a mouse xenograft model, Ligase 1 loss led to complete tumor stasis.27PubMed Central. LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers Separate work in prostate cancer found that combining a Ligase 1 inhibitor with the PARP inhibitor olaparib produced a synergistic effect, suppressing tumor growth in mice while sparing normal tissue. Ligase 1 was also found to be overexpressed in castration-resistant prostate cancer tissue, suggesting it could serve as both a biomarker and a target.28PubMed Central. Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer
Earlier work took a complementary approach: rationally designing small molecules that inhibit specific human DNA ligases and then testing whether those inhibitors make cancer cells more sensitive to existing DNA-damaging treatments like radiation or alkylating agents. Two such compounds, L67 and L189, significantly increased killing of breast and colon cancer cells by DNA-damaging agents at concentrations that had little effect on normal breast epithelial cells.29Cancer Research. Rational Design of Human DNA Ligase Inhibitors that Target Cellular DNA Replication and Repair The selectivity for cancer cells likely reflects the fact that many tumors already have repair defects, making them more dependent on the ligase-mediated pathways that remain.
Ligating More Than Just DNA-DNA Junctions
Although DNA ligase is named for its work on DNA, some ligases can seal junctions involving RNA. Vaccinia virus DNA ligase, for instance, efficiently joins a 3′-OH RNA strand to a 5′-phosphate DNA strand when both are aligned on a DNA template. The RNA-to-DNA joining activity is robust, while RNA-to-RNA ligation under the same conditions is extremely weak, about 10,000 times less efficient.30PubMed. Ligation of RNA-containing duplexes by vaccinia DNA ligase A different viral ligase, from the Chlorella virus PBCV-1, ligates DNA that is splinted by an RNA strand far more efficiently than T4 DNA ligase can manage the same task.31Nucleic Acids Research. Efficient DNA ligation in DNA–RNA hybrid helices by Chlorella virus DNA ligase These activities are more than curiosities: they have practical applications in constructing hybrid molecules for research and may reflect biological roles in how certain viruses manipulate host genetic material. They also hint that the boundary between “DNA ligase” and “RNA ligase” is blurrier than textbook categories suggest, with substrate specificity varying considerably across enzyme families.